The Latest Cardiac and Vascular News
POSEIDON – positive interim results in Q4 2020; additional interim results expected in Q2 2021 and primary endpoint in Q2 2022 RED DESERT – positive interim results in Q4 2020; top-line data expected in Q2 2021 Successful equity placements extend cash runway into Q2 2022 Conference call with live webcast today at […]
March 8, 2021, filing to raise up to $75 million. Maximum of 1,500,000 shares of Series B preferred stock offered at price of $50 per share. Healthtech Solutions, Inc. is organized to pursue innovation in the field of medical technology. NEW YORK, March 17, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Healthtech […]
Device offers a streamlined approach for lower extremity embolic protection ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in the U.S. have been treated […]
Menlo Ventures, UCHealth invest to bring comprehensive hypertension measurement and management to the phone PALO ALTO, Calif.–(BUSINESS WIRE)–Riva Health, a new mobile cardiology app, today announced $15.5M in funding led by Menlo Ventures. UCHealth and University of Colorado Innovation Fund also participated in the round, as well as leading Chicago healthcare […]
LA ROCHELLE, France–(BUSINESS WIRE)–Regulatory News: 2020 highlights and results Global strategic partnership with Nestlé Health Science for the development and marketing of TOTUM-63, a plant-based active substance with clinically proven metabolic health benefits in prediabetic subjects. Launch of REVERSE-IT, a global pivotal Phase II/III clinical trial of TOTUM-63 for reducing […]
–Galaxy’s proprietary CENTAURI™ system on track for EU registration and US pivotal trial start later this year; shows best-in-class potential SAN CARLOS, Calif., March 16, 2021 /PRNewswire/ — ATP, a leader in life science venture capital, announced today $18M in Series A financing for its portfolio company Galaxy Medical, Inc. The funds are being […]
COPENHAGEN, Denmark, March 16, 2021 /PRNewswire/ — CathVision ApS, a medical device company developing a novel artificial intelligence therapeutic platform for cardiac electrophysiology procedures, is announcing a change to its Board of Directors. Meghna Eichelberger, Partner and Associate Director of Medical Technologies, at The Boston Consulting Group (BCG), has joined CathVision’s Board […]
PORTLAND, Ore., March 16, 2021 /PRNewswire/ — VisCardia Inc., a privately held medical device developer, announced today that the American Medical Association (AMA) has issued (ten) 10 new Current Procedural Terminology (CPT®) Category III codes in support of the implant procedure and management of Synchronized Diaphragmatic Stimulation (SDS®) therapy as provided through VisCardia’s […]
MINNEAPOLIS, March 16, 2021 /PRNewswire/ — Imbio, a leading provider of artificial intelligence (AI) solutions for medical imaging analysis, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its RV/LV Analysis™ algorithm. The RV/LV Analysis algorithm is a rapid, automated assessment of potential right ventricular dilation. The tool quickly and accurately measures the […]
CHENNAI, India, March 16, 2021 /PRNewswire/ — The Apollo Hospitals group, one of Asia’s largest and most trusted healthcare group, notched up a record milestone with the successful completion of four consecutive MitraClip procedures in one day. The MitraClip implants were carried out on four patients suffering from severe heart failure on the same […]
